Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Borrow rate
99.39%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — |
| R&D | $22.9M | $25.5M | $41.7M | $37.0M | $43.1M | $57.0M |
| Operating income | −$28.9M | −$33.9M | −$57.4M | −$53.8M | −$61.8M | −$72.8M |
| EBITDA | −$27.6M | −$32.8M | −$55.6M | −$53.1M | −$61.4M | −$77.8M |
| Net income | −$30.9M | −$36.1M | −$60.0M | −$58.8M | −$67.1M | −$81.2M |
| Net margin | — | — | — | — | — | — |
| EPS (diluted) | -1.87 | -2.18 | -3.61 | -1.85 | -1.76 | -1.27 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds AXLA.
No tracked institution reports a position in AXLA as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-09-19 | 1-for-25reverse |
No one on the platform has traded AXLA yet.
| $146M |
| — |
| KRROKorro Bio, Inc. | $13.20 | +3.90% | $131M | — |
| NTBLNotable Labs, Ltd. | $0.25 | -27.68% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
@badprecog $AXLA Yup. This is likely their biggest decision of the year. If they were going to approve they would still want the oral argument. This is too high profile of a drug.
View on StockTwits ↗$AXLA Axcella Health Inc. (NASDAQ:AXLA): Navigating the Challenges of a Biotechnology Startup https://beyondspx.com/article/axcella-health-inc-nasdaq-axla-navigating-the-challenges-of-a-biotechnology-startup
View on StockTwits ↗$AXLA Axcella Health Inc. (NASDAQ:AXLA): Navigating the Challenges of a Biotechnology Startup http://beyondspx.com/2024/08/05/axcella-health-inc-nasdaqaxla-navigating-the-challenges-of-a-biotechnology-startup/
View on StockTwits ↗@can_t_lan @AlexKingUkr Unfortunately you just don’t understand and I can’t explain it. $AXLA $AFIB and so many more same thing. You’ll learn. Hopefully you get in and out with gains.
View on StockTwits ↗$JAGX NDA filing right after topline announcement. FDA approval very likely per below. Short a .09 bio with imminent fda approval. F around and find out! Just ask LHDXQ, $CYTOF , or $AXLA how that went!
View on StockTwits ↗$AXLA guys this stock is delisting...what with the money ?
View on StockTwits ↗$AXLA Hey folks - Do you remember the scam of the year 2023 and a Flagship Pioneering - they have all your money?
View on StockTwits ↗$AXLA Funny how it started tanking 2 weeks before this statement was made. Insider trading much?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.